Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial | MicrobiomeTrials← Back to trialsNCT02603328
Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2018-07-17Est. Completion: 2024-07-31
Enrollment target: 80 participants Locations- University of Chicago, Chicago, Illinois, United States
Other microbiome trials you might be interested in
Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma
Cerebral cavernous malformations (CCMs) are clusters of abnormal blood vessels in the brain and spine. CCMs can bleed an…
Phoenix, United StatesCompleted Mar 31, 2025
Cerebral Cavernous Malformation
This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, efficacy…
Phoenix, United StatesCompleted Jun 30, 2025
Recruiting
CADASILCavernous AngiomaCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathySmall Vessel Disease
CERVCO is the French National Reference Centre for Rare Cerebrovascular and Retinal Diseases, accredited by the Ministry…
Multiple LocationsEst. completion Jun 30, 2038